TL;DR
The CAPS program is a multi-modal digital health intervention—combining a mobile app, wearables, and a clinician portal—designed to help stroke and TIA survivors manage their recovery and prevent secondary events. This feasibility study demonstrates high patient engagement and usability, suggesting that a "closed-loop" digital assistant can successfully integrate into the daily lives of patients to support long-term self-monitoring.
What Problem Does This Paper Address?
After a stroke or transient ischemic attack (TIA), the risk of a secondary event remains high. Effective "secondary prevention" requires rigorous management of risk factors like blood pressure, physical activity, and medication adherence. However, transitioning from acute hospital care to community-based self-management is often a "cliff edge" for patients.
Existing solutions are often fragmented. The authors address this by testing the Care Assistant and support Program for people after Stroke (CAPS), a clinician-led digital ecosystem designed to bridge the gap between clinical oversight and patient daily life. The goal was to determine if such a complex, tech-heavy intervention is actually feasible and acceptable for both survivors and the clinicians who would theoretically manage them.
Methods
The researchers conducted a 12-week, open-label, single-group, mixed-methods evaluation.
- The Tech Stack: The CAPS intervention consists of four integrated components:
- A web-based clinician portal for monitoring.
- SMS messages aligned with personal goals.
- A mobile application for data entry and tracking.
- A wearable device for passive data collection.
- Evaluation: They used the System Usability Scale (SUS) to quantify app quality and conducted focus groups with ten clinicians (including neurologists, nurses, and GPs) to gather qualitative feedback on the program's design and delivery model.
- Participants: Lived-experience participants were recruited via the Australian Stroke Clinical Registry (AuSCR).
Datasets
As a feasibility and human-factors study, the "datasets" involved are the participant cohorts and the telemetry from the CAPS platform:
- Lived-experience cohort: 34 eligible participants (recruited from 600 invitations).
- Clinician cohort: 10 professionals (3 nurses, 3 allied health, 2 neurologists, 1 stroke consultant, 1 GP).
- Usage Data: Logs of health data reviews and measurement entries (e.g., blood pressure, steps) over the 12-week period.
Key Insights and Ideas
- High "Stickiness" in a Clinical Population: Despite the challenges often associated with post-stroke recovery (e.g., cognitive or motor impairments), participants engaged with the app an average of twice per day. This suggests that the "digital assistant" model provides enough perceived value to overcome the friction of manual data entry.
- The "Golden Window" for Intervention: Clinicians highlighted that the timing of the intervention is critical. Seven out of ten clinicians believed the program would be most effective if initiated within the first three months post-discharge, capitalizing on the period when patients are most motivated to make lifestyle changes.
- Primary Care is the Hub: While stroke care often starts in specialized wards, six clinicians indicated that a GP-led multidisciplinary model is the most sustainable way to deliver this digital program long-term, rather than keeping it within the silo of hospital neurology departments.
- Closing the Loop: The program isn't just a tracker; it's a communication tool. The integration of "goal-aligned SMS" suggests that personalized, automated feedback is a key driver of engagement.
Key Results
- Usability: The CAPS app received a SUS rating of "Good" to "Excellent."
- Engagement: Participants entered health measurements an average of 73 times over 12 weeks. More than 60% of participants maintained sustained usage until the end of the study.
- Acceptability: Over 90% of participants reported that the program fitted well into their daily routines and helped with self-monitoring.
- Future Intent: 76% of participants stated they would continue to use the program if it were publicly available.
- Clinician Sentiment: 80% of participating clinicians had positive perceptions, specifically noting that the app captured "vital information" necessary for secondary prevention.
Limitations and Future Work
The most notable limitation is the recruitment yield: only 34 participants commenced the program out of 600 invitations. This suggests a potential selection bias toward more tech-savvy or highly motivated individuals, which may not represent the broader stroke survivor population.
Future Directions: * Feature Expansion: Clinicians recommended adding tracking for atrial fibrillation (AFib) and blood cholesterol to make the clinical data more comprehensive. * Phase II Trial: The authors are using these findings to inform the design of a Phase II randomized feasibility trial, which will likely focus on the GP-led delivery model and the three-month post-discharge window.
Summary updated